Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|March 3, 1984
Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumoursD H Carr, J Brown, G M Bydder, et al.
Cancer Biomarkers : Section a of Disease Markers|May 18, 2011
Quantifying sclerotic bone metastases with 2D ultra short TE MRI: a feasibility studyC Messiou, D J Collins, V A Morgan, et al.
Journal of Computer Assisted Tomography|September 1, 1988
Use of phosphorus-31 MR spectroscopy to monitor response to chemotherapy in non-Hodgkin lymphomaD J Bryant, G M Bydder, H A Case, et al.
The British Journal of Radiology|July 19, 2002
Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's diseaseK M Bradley, G M Bydder, M M Budge, et al.
Journal of Computer Assisted Tomography|January 1, 1991
MR imaging of anisotropically restricted diffusion of water in the nervous system: technical, anatomic, and pathologic considerationsJ V Hajnal, M Doran, A S Hall, et al.
Investigative Radiology|May 1, 1984
Effect of oxygen tension on NMR spin-lattice relaxation rate of blood in vivoA Tripathi, G M Bydder, J M Hughes, et al.
AJR. American Journal of Roentgenology|August 1, 1984
Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patientsD H Carr, J Brown, G M Bydder, et al.
Pageof 18